Transaction - Truenewj

Neurocrine will acquire Soleno in a transaction of 2.9 billion dollars

amefika2 months ago02 mins

Neurocrine Biosciences has entered into a definitive agreement to acquire Soleno Therapeutics for $53 per share in cash, representing $2.9 billion in total transaction equity value. The transaction will expand Neurocrine’s portfolio in endocrinology and rare diseases by adding Soleno’s lead product, Vykat XR (diazoxide choline), for Prader-Willi syndrome (PWS). Vykat XR is a first-in-class…

Vistra expands its gas fleet with the acquisition of Cogentrix for billion

Vistra expands its gas fleet with the acquisition of Cogentrix for $4 billion

amefika5 months ago04 mins

Vistra Corp. (VST) has reached a deal to significantly expand its U.S. generation footprint, agreeing to acquire the portfolio of Cogentrix Energy in a transaction valued at approximately $4 billion, including assumed debt and tax benefits. The acquisition brings approximately 5,500 megawatts of modern natural gas-fired capacity to Vistra’s fleet, strengthening its position in three…